These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19504102)

  • 1. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
    Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Tamai K; Koyama T; Saga T; Morisawa N; Fujimoto K; Mikami Y; Togashi K
    Eur Radiol; 2008 Apr; 18(4):723-30. PubMed ID: 17929022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
    Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
    Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
    Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
    Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
    Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
    Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
    Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
    J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to differentiate benign from malignant myometrial tumours using MR imaging.
    Thomassin-Naggara I; Dechoux S; Bonneau C; Morel A; Rouzier R; Carette MF; Daraï E; Bazot M
    Eur Radiol; 2013 Aug; 23(8):2306-14. PubMed ID: 23563602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microstructural changes in uterine leiomyomas and myometrium: a diffusion-weighted magnetic resonance imaging study.
    Erdem G; Celik O; Karakas HM; Hascalik S; Firat AK
    Gynecol Obstet Invest; 2009; 67(4):217-22. PubMed ID: 19169036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
    Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
    Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
    Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
    Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
    Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization.
    Lee MS; Kim MD; Jung DC; Lee M; Won JY; Park SI; Lee DY; Lee KH
    J Vasc Interv Radiol; 2013 Sep; 24(9):1361-5. PubMed ID: 23891046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of ADC Values for Differentiating Uterine Sarcomas From Leiomyomas: Systematic Review and Meta-Analysis.
    Woo S; Beier SR; Tong A; Hindman NM; Vargas HA; Kang SK
    AJR Am J Roentgenol; 2024 Sep; 223(3):e2431280. PubMed ID: 38899844
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.
    Sutter O; Soyer P; Shotar E; Dautry R; Guerrache Y; Placé V; Opréa R; Ricbourg A; Le Dref O; Boudiaf M; Sirol M; Dohan A
    Eur Radiol; 2016 Oct; 26(10):3558-70. PubMed ID: 26801165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.
    Takeuchi M; Matsuzaki K; Harada M
    Eur Radiol; 2013 Sep; 23(9):2358-63. PubMed ID: 23740024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas.
    Gerges L; Popiolek D; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 May; 210(5):1172-1177. PubMed ID: 29547053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.